A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)

NCT03168321 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

813

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: IDP-123 Lotion
DRUG: IDP-123 Vehicle Lotion

Sponsor

Bausch Health Americas, Inc.